MedTrace Logo

Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection

NCT05545137 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 299

Last updated 2024-04-17

No results posted yet for this study

Summary

the purpose of this study is to evaluate the efficacy and safety of pivmecillinam hydrochloride tablets in the treatment of uncomplicated urinary tract infection in China

Conditions

  • Uncomplicated Urinary Tract Infection

Interventions

DRUG

Pivmecillinam hydrochloride tablets

400mg tablet

DRUG

Fosfomycin Tromethamine Granules

3g/pack

Sponsors & Collaborators

  • Benova (Tianjin) Innovative medicine Research Co., Ltd.

    lead OTHER

Principal Investigators

  • Xiangdong Yang, PhD · Qilu Hospital of Shandong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-29
Primary Completion
2024-02-05
Completion
2024-02-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05545137 on ClinicalTrials.gov